中华眼外伤职业眼病杂志
中華眼外傷職業眼病雜誌
중화안외상직업안병잡지
CHINESE JOURNAL OF OCULAR TRAUMA AND OCCUPATIONAL EYE DISEASE
2014年
3期
213-215
,共3页
高眼压%持续状态%前房穿刺术,改良式
高眼壓%持續狀態%前房穿刺術,改良式
고안압%지속상태%전방천자술,개량식
Pressure,intraocular,high%State,continuous%Paracentesis,anterior chamber,modified
目的 探讨改良式前房穿刺术在青光眼持续高眼压状态下的效果.方法 35例(38眼)持续高眼压青光眼,急性闭角型青光眼急性发作期21例(24眼),慢性闭角型青光眼6眼,新生血管性青光眼4眼,年龄相关性白内障膨胀期4眼.所有患眼应用常规降眼压药物不能有效降低眼压,采用手术显微镜下改良式前房穿刺术放液.结果 所有患者放液后眼压迅速降低,眼痛、头痛缓解,视力有不同程度提高,术后眼压平均为(17.30±5.40) mmHg(1 mmHg =0.133 kPa).结论 改良式前房穿刺术放液是治疗高眼压持续状态的安全、有效的方法,损伤小、反应轻、简便高效,可以避免长期大量应用降眼压药物引起的副作用.
目的 探討改良式前房穿刺術在青光眼持續高眼壓狀態下的效果.方法 35例(38眼)持續高眼壓青光眼,急性閉角型青光眼急性髮作期21例(24眼),慢性閉角型青光眼6眼,新生血管性青光眼4眼,年齡相關性白內障膨脹期4眼.所有患眼應用常規降眼壓藥物不能有效降低眼壓,採用手術顯微鏡下改良式前房穿刺術放液.結果 所有患者放液後眼壓迅速降低,眼痛、頭痛緩解,視力有不同程度提高,術後眼壓平均為(17.30±5.40) mmHg(1 mmHg =0.133 kPa).結論 改良式前房穿刺術放液是治療高眼壓持續狀態的安全、有效的方法,損傷小、反應輕、簡便高效,可以避免長期大量應用降眼壓藥物引起的副作用.
목적 탐토개량식전방천자술재청광안지속고안압상태하적효과.방법 35례(38안)지속고안압청광안,급성폐각형청광안급성발작기21례(24안),만성폐각형청광안6안,신생혈관성청광안4안,년령상관성백내장팽창기4안.소유환안응용상규강안압약물불능유효강저안압,채용수술현미경하개량식전방천자술방액.결과 소유환자방액후안압신속강저,안통、두통완해,시력유불동정도제고,술후안압평균위(17.30±5.40) mmHg(1 mmHg =0.133 kPa).결론 개량식전방천자술방액시치료고안압지속상태적안전、유효적방법,손상소、반응경、간편고효,가이피면장기대량응용강안압약물인기적부작용.
Objective To investigate the effect of modified anterior chamber paracentesis in glaucoma patients with sustained high intraocular pressure.Methods 38 eyes of 35 cases of glaucoma with continuous state of elevated intraocular pressure were enrolled in the study.There were 21 case of acute angleclosure glaucoma,6 cases of chronic angle-closure glaucoma,4 cases of neovascular glaucoma,4 cases of secondary glaucoma with age-related cataract in intumescent stage.The intraocular pressure of patients could not be reduced effectively by medical treatment.The modified anterior chamber paracentesis was performed in all the patients under operating microscope.Results The eye pain and headache were relieved and the visual acuity was improved in all the patients.The average intraocular pressure was(17.30 ± 5.40)mm Hg(1 mm Hg =0.133 kPa)after the procedure.Conclusion Modified anterior chamber paracentesis is safe and effective with slight damage to the tissue and slight inflammatory reaction in the management of sustained high intraocular pressure which avoids the side effects caused by long term application of antiglaucoma medication.
